1. Fujibayashi Y, Matsumoto K, Yonekura Y, Konishi J, Yokoyama A. A new zinc-62/copper-62 generator as a copper-62 source for PET radiopharmaceuticals.J Nucl Med 30: 1838–1842, 1989.
2. Fujibayashi Y, Wada K, Taniuchi H, Yonekura Y, Konishi J, Yokoyama A. Mitochondria-selective reduction of62Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) (62Cu-PTSM) in the murine brain; a novel radiopharmaceutical for brain positron emission tomography (PET) imaging.Biol Pharm Bull 16: 146–149, 1993.
3. Matsumoto K, Fujibayashi Y, Yonekura Y, Wada K, Takemura Y, Konishi J, et al. Application of the new zinc-62/copper-62 generator: an effective labeling method for62Cu-PTSM.Nucl Med Biol 19: 39–44, 1992.
4. Okazawa H, Yonekura Y, Fujibayashi Y, Nishizawa S, Magata Y, Ishizu K, et al. Clinical application and quantitative evaluation of generator-produced copper-62-PTSM as a brain perfusion tracer for PET.J Nucl Med 35: 1910–1915, 1994.
5. Wada K, Fujibayashi Y, Taniuchi H, Tajima N, Tamaki N, Konishi J, et al. Effects of ischemia-reperfusion injury on myocardial single pass extraction and retention of Cu-PTSM in perfused rat hearts: comparison with201T1 and14C-iodoantipyrine.Nucl Med Biol 21: 613–617, 1994.